Bayer is trading at €53.92, down 4.09%, with no clear Bayer-specific announcement explaining the November 6 decline. - Healthcare stocks are down 1.48%, which may be contributing to pressure but does not establish a direct cause. - The decline follows a strong recent rise, including a 3.65% gain on November 5; the earlier rally followed Q3 results and a higher full-year outlook.